Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,467 | -25,664 | -7,581 | -18,292 | -72,111 |
| Depreciation Amortization | -1,227 | 823 | 531 | 264 | 1,055 |
| Accounts receivable | 5,819 | 7,303 | 8,018 | 11,164 | -11,165 |
| Other Working Capital | 14,436 | 11,855 | 6,939 | 15,353 | 12,539 |
| Other Operating Activity | -1,793 | -4,642 | -6,260 | -10,282 | 15,271 |
| Operating Cash Flow | $-25,232 | $-10,325 | $1,647 | $-1,793 | $-54,411 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -41 | -29 | -12 | -186 |
| Investing Cash Flow | $-41 | $-41 | $-29 | $-12 | $-186 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,444 | -3,333 | -2,222 | -1,111 | -2,963 |
| Common Stock Issued | 12,489 | 11,055 | 10,754 | 8,756 | 11,055 |
| Other Financing Activity | 36,552 | 0 | 0 | 0 | 29,186 |
| Financing Cash Flow | $44,597 | $7,722 | $8,532 | $7,645 | $37,278 |
| Beginning Cash Position | 42,949 | 42,949 | 42,949 | 42,949 | 60,268 |
| End Cash Position | 62,273 | 40,305 | 53,099 | 48,789 | 42,949 |
| Net Cash Flow | $19,324 | $-2,644 | $10,150 | $5,840 | $-17,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,232 | -10,325 | 1,647 | -1,793 | -54,411 |
| Capital Expenditure | -41 | -41 | -29 | -12 | -186 |
| Free Cash Flow | -25,273 | -10,366 | 1,618 | -1,805 | -54,597 |